Triferic (Ropack Inc.)


Welcome to the PulseAid listing for the Triferic drug offered from Ropack Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ropack Inc.
NON-PROPRIETARY NAME: FERRIC PYROPHOSPHATE CITRATE
SUBSTANCE NAME: FERRIC PYROPHOSPHATE CITRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: PARENTERAL
DOSAGE FORM: POWDER
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-11-28
END MARKETING DATE: 0000-00-00


Triferic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTriferic from Ropack Inc.
LABELER NAME: Ropack Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 272(mg/272mg)
START MARKETING DATE: 2016-11-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64811-315_425df869-79f6-481b-e054-00144ff88e88
PRODUCT NDC: 64811-315
APPLICATION NUMBER: NDA208551

Other FERRIC PYROPHOSPHATE CITRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rockwell Medical, IncTriferic
Ropack Inc.Triferic